samedan logo
 
 
spacer
home > epc > winter 2001 > the trojan horse of oncology - the role of stealth drug delivery
PUBLICATIONS
European Pharmaceutical Contractor

The Trojan Horse of Oncology - The Role of Stealth Drug Delivery

The word 'cancer' instils fear into most people. One in four people will develop cancer at some point in their life and, given the dismal cure rates for most common cancers, many of those who are diagnosed with some form of the disease will eventually die of it. Fear is often augmented by the knowledge that the relentlessly growing cancer often brings with it pain, suffering and debility.

Far from being 'mindless' automatons, it has been shown that tumour cells employ numerous strategies to promote growth. Complicated mechanisms to switch on growth; vascular endothelial growth factors (VEGF) to create a blood supply as a pipeline to bring nutrients; and pumps such as p-Glycoprotein to get rid of ingested cellular toxins are some of the strategies that have evolved.

While the fight against cancer begins with prevention, once it has developed, permanent eradication of the disease requires all the skills oncologists can muster to outwit the tumour cell and the mechanisms it employs to ensure its continued cellular survival and tumour growth.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Peter Cheverton MBChB, MMed Rad(T), Director of Oncology for Daiichi Pharmaceuticals UK Ltd

Peter Cheverton is an Oncologist who spent 20 years in clinical practice before joining the pharmaceutical industry in 1990. He has worked for Lederle, ASTA Medica and has been Director of Oncology for Daiichi Pharmaceuticals UK Ltd for over three years. Peter works in European oncology development as part of the Daiichi Global Oncology Programme.

spacer
Dr Peter Cheverton
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

ICSE Europe

5-7 October 2010, Paris, France

ICSE is the international stage for companies providing outsourcing services in clinical trials, contract research, custom manufacturing, biotechnology, IT, analytical services, packaging services and logistics. For over 10 years, ICSE has been connecting buyers and sellers in the market of (bio)pharmaceutical and pharma-related contract services. With a keen eye for new needs and new developments, each ICSE event is set up to fulfil its role as meeting place and intermediary as effectively as possible.
More info >>

 
News and Press Releases

The highest performance in its class

Shimadzu, one of the worldwide leading manufacturers in analytical instrumentation, has launched a new GCMS-QP2010 Ultra gas chromatograph mass spectrometer (GC/MS) offering the highest performance in its class. It provides fast data measurement speed with five times higher sensitivity than previous models. In addition to improving laboratory productivity for high-speed analysis, it also offers improved applicability for comprehensive two-dimensional gas chromatography (GCxGC), which can achieve ultra high separation. It is also the first GC/MS system to have environmentally friendly features for saving power consumption and carrier gas.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement